Magnetic nanohybrids for cancer therapy – 2019–2022
Project’s webpage: Project in CORDIS.eu
Projects – Twinning | Horizon 2020

Magnetic Nanohybrids for Cancer Therapy
Magnetic nanohybrids (MNHs) based on biocompatible magnetic ferrites provide a unique toolbox for theranostics applications, since they can be remotely and non-invasively employed as smart actuators and carrier vectors.

Among their major advantages are the tunable magnetic features, the biocompatibility, the diversity of functionalization, and the appropriate size scale comparable to functional biomolecules. Not only can MNHs be functional by themselves, such as hyperthermia mediators in cancer treatment, but they can also be useful as a drug carrier and actuators for a thermally or mechanically controlled drug release. Additionally, magnetically driven mechanical forces can selectively be applied to trigger certain biological functions to determine cell growth or death.

MaNaCa training workshops in Thessaloniki:

• April 07–09, 2022

• August 25–28, 2020